Project Grant R01NS136987
- This NSF Engineering Program award of $605,320 to North Carolina State University (NC State) supports the development of a flexible, FMRI-compatible neural probe with multi-modal sensing and modulation capabilities. The novel probe is designed to advance understanding of neural circuit dynamics and enable closed-loop neuromodulation for treating neurological disorders. Key product elements include: Flexible, multi-shank neural probe fabricated using polymeric materials to enable deep brain...
- This Project Grant award from the National Science Foundation (CFDA 47.074 Biological Sciences) is for the development of a piezoelectric inchworm machine to enable automated implantation of miniaturized flexible microelectrodes into the brain for large-scale chronic neural recordings. The $499,991 award will fund the development of the inchworm insertion mechanism and its integration with a 3D-printed skull cap platform. This system aims to address the challenges of electrode buckling and...
- The National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $522,673 Project Grant to the University of Chicago from October 1, 2021 to September 30, 2024. The grant supports research titled "Optically-Controlled Neuromodulation with Silicon Carbide-Based Nanostructures" under the NSF Engineering program (CFDA 47.041). The grant aims to develop optically-controlled neuromodulation technologies using silicon carbide...
- This Project Grant awarded by the National Science Foundation (CFDA 47.041 - Engineering) to Cleveland State University (CSU) provides $500,000 in funding from January 1, 2025 to December 31, 2027 to develop bioprinted tissue scaffolds with Schwann cell density gradients and electrical conductivity for peripheral nerve regeneration. The goal is to understand how Schwann cell density gradients and electrical properties within the scaffolds can enhance the regeneration of injured peripheral...
- This $2.72 million Project Grant award from the National Institute of Neurological Disorders and Stroke under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) supports the development of advanced high-speed imaging sensors and microscopy methods at the Massachusetts Institute of Technology. The award, which commenced August 1, 2025 and concludes July 31, 2028, funds the design and fabrication of novel complementary...
- Federal Project Grant Award Summary Spike Neuro LLC received a $397,650 project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 1, 2025, with completion targeted for November 30, 2026. In partnership with the University of Michigan, Spike Neuro is developing a flexible carbon fiber penetrating nerve cuff and cortical array designed for neural recording, stimulation, and neurochemical detection. The project...
- Federal Cooperative Agreement Summary The National Institute of Neurological Disorders and Stroke awarded a Cooperative Agreement totaling $953,287 to The Trustees of Columbia University in the City of New York (Health Sciences Division) for the development of NEUROFLEX—wireless, mechanically flexible, stimulation-capable depth and surface high-density microelectrode arrays for epilepsy monitoring. The project addresses critical limitations in current intracranial electrocorticography (ECoG)...
- This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provides $319,999 to the University of Notre Dame to develop an implantable neural interface platform with three key innovations: 1) optimized resistive RAM memory for efficient data storage, 2) programmable analog front-end circuits for high-density neural signal acquisition, and 3) specialized processors for energy-efficient computation of neural network operations. The goal is to create an...
- This federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $630,000 to the University of Chicago to develop a new technology called the Monolithic Adjustable Photostimulation (MAP) platform for high spatiotemporal photostimulation of the nervous system. The project aims to create minimally-invasive, optically-controlled neuromodulation devices using advanced silicon heterojunctions that can precisely stimulate neural circuits, with the goal...
- Federal Project Grant Award Summary The National Science Foundation (NSF) Engineering program (CFDA 47.041), administered through the Division of Chemical, Bioengineering, Environmental, and Transport Systems, awarded a collaborative research project grant of $325,000 to Massachusetts Institute of Technology (MIT) effective August 1, 2025, with completion targeted for July 31, 2028. This project grant will fund the development of 3D-integrated micro-photometer chips designed to advance in vivo...
SCALABLE FABRICATION OF HIGH-DENSITY AMORPHOUS SILICON CARBIDE MICROELECTRODE ARRAYS FOR CHRONIC NEURAL INTERFACING - PROJECT SUMMARY INTRACORTICAL MICROELECTRODE ARRAYS HAVE LONG BEEN USED TO RECORD NEURAL ACTIVITY IN BASIC SCIENCE AND CLINICAL RESEARCH STUDIES OF THE BRAIN. TO DATE, CARBON FIBER MICROELECTRODES HAVE ACHIEVED THE HIGHEST QUALITY NEURAL RECORDING DATA WITH MINIMAL IMMUNE RESPONSE AFTER IMPLANTATION, BUT THE TECHNIQUES REQUIRED TO FABRICATE CARBON FIBER ARRAYS DO NOT ALLOW FOR THE MANUFACTURING SCALE REQUIRED FOR NEXT-GENERATION DEVICES. RECENT ADVANCES IN THIN-FILM FABRICATION HAVE LED TO A NEW CLASS OF FLEXIBLE MICROELECTRODE ARRAYS BUT THEY REQUIRE AN ECOSYSTEM OF COMPLEX IMPLANTATION FIXTURES, LIMITING THEIR WIDESPREAD ADOPTION. AS A RESULT, THIN-FILM DEVICES WITH NEURAL RECORDING QUALITY EQUIVALENT TO CARBON FIBER ELECTRODES HAVE SO FAR ELUDED THE NEURAL ENGINEERING COMMUNITY. THIS PROJECT AIMS TO USE SCALABLE FABRICATION METHODS TO DEVELOP SELF-INSERTING 128-CHANNEL ULTRA-MICROELECTRODE ARRAYS WITH UNMATCHED RECORDING LONGEVITY. BY PROVIDING HIGH-QUALITY NEURAL SIGNALS OVER LONGER PERIODS, WE AIM TO ADVANCE STUDIES OF LONG-TERM CHANGES IN NEURAL CIRCUITS AND IMPLICATIONS FOR CLINICAL TREATMENTS OF NEUROLOGICAL DISORDERS. TO ACCOMPLISH THIS, THE PROJECT USES AMORPHOUS SILICON CARBIDE IN STANDARD THIN FILM FABRICATION. THE ELECTRODE ARRAYS ARE FABRICATED IN A FORM FACTOR EASILY IMPLANTED IN THE BRAIN WITHOUT ANY COMPLEX IMPLANTATION MECHANISMS. THE HIGH DENSITY OF MICROELECTRODES AND ULTRA-SMALL DIMENSIONS OF EACH INSERTED SHANK ARE DESIGNED TO ELICIT MINIMAL IMMUNE RESPONSE. THE FOCUS OF THIS PROJECT IS A VALIDATION OF THE FABRICATION METHODS AND DEVICE RECORDING CAPABILITIES THROUGH A SERIES OF ENGINEERING STEPS AS WELL AS IN VITRO AND IN VIVO TESTING. SPECIFICALLY, THE PROJECT SEEKS TO REFINE THE FABRICATION PROCESS FOR SCALABLE PRODUCTION OF 128-CHANNEL ULTRA-MICROELECTRODE ARRAYS AND TO ESTABLISH SINGLE UNIT YIELD, STABILITY, AND CHRONIC TISSUE RESPONSE FOR DEVICES IN SMALL ANIMAL MODELS. ENGINEERING STEPS INCLUDE DESIGN VARIATIONS TO ESTABLISH REPEATABLE FABRICATION OF AMORPHOUS SILICON CARBIDE ARRAYS WITH CROSS-SECTION DIMENSIONS BELOW 10 MM THAT INSERT WITHOUT THE NEED FOR ADDITIONAL GUIDES, SHUTTLES, OR OTHER STRUCTURES. FINALLY, THE PROJECT SEEKS TO QUANTIFY THE PERFORMANCE OF THE DEVICES IN MULTI-MONTH IN VIVO STUDIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $655.8k | 8/5/25 | ||
| Not listed | $301.2k | 7/30/24 |